<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171206037774N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-04</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The Effect Of Venous Magnesium Sulfate On Pain Relief In Patients With Acute Renal Colic</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation Of The Effect Of Intravenous Magnesium Sulfate On Pain Relief In Patients With Acute Renal Colic- A Randomized Double Blind Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28511</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple Randomization 
 Table Of Random Numbers, Blinding description: Due To The Double-Blindness Of The Study, Throughout The Study, The Patients, Physicians, Nurse-Injectors Were Unaware Of All Stages Of The Study, And The Preparation And Injection Of Medications By Two Nurses Or Residents Was Carried Out So That The Person Preparing The Medication From The Recipient The Medication And The Nurse Injecting Drug Was Unaware. All Drug Injection Syringes Were United And Randomized And Recorded By One Person (Emergency Medicine Assistant).</study_design>
      <phase>2-3</phase>
      <hc_freetext>Acute Renal Colic.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group: Patients With Acute Renal Colic In This Group Received Magnesium Sulfate At A Dose Of 2 G Of 50% Solution At 100 Cc At 15 Minutesmagnesium sulfate at a dose of 2 g of 50% solution at 100 cc at 15 minutes. Intervention 2: Control group: In Patients With Acute Renal Colic, Morphine Was Administered At A Dose Of 0.1 Mg / Kg To 100 Cc At 15 Minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All Collected Data Will Analyzed Then Will Accessible To All In The Form Of A Dissertation As Well As A Published Article.

When:
After Publishing the Paper.

To whom:
All Collected Data Will Analyzed Then Will Accessible To All In The Form Of A Dissertation As Well As A Published Article.

Conditions:
All Collected Data Will Analyzed Then Will Accessible To All In The Form Of A Dissertation As Well As A Published Article.

Where to obtain:
The Journal Website

How to obtain:
Search in Databases

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Arehemi Dolatabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tajrish Square</address>
        <city>Teharn</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1918141512</zip>
        <telephone>+98 21 25719</telephone>
        <email>dr.fatemeh.derakhshani62@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Majidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tajrish Square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1819141512</zip>
        <telephone>+98 21 25719</telephone>
        <email>alirezamajidi330@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The Adult Patients With Acute Renal Colic Are Between The Ages Of 18-60 And The Severity Of Pain Between 6 To 10 Based On The VAS Criteria And GCS= 15.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy Or Suspicion Of Pregnancy, History Of Alcohol Addiction Sensitization To Morphine Or Pain Medication, History Of Mental Illness And Depression And Recent Sedation Or Antipsychotics And Calcium Intake Of Blocker Channel, History Of Drug Dependence, Receiving Analgesic In 6 Recent Illness, Neuromascular Disease And Underlying Bradycardia (Heart Rate Less Than 60), Long Qrs Interval, History Of Heart And Kidney Disease, Liver And Liver Disease, Seizure And History Of Drop In Pressure, Abdominal Pain And Probability Of Peritonitis, Lack Of Consent Of The Patient From Continuing The Study, Unstable Patient With Clinical Condition And Pressure Drop (Systolic Pressure Less Than 90 Or Pressure Foot 20% Of The Base) And A Drop In Heart Rate To Less Than 8, And A Drop In Respiratory Rate To Less Than 60 During The Study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N23</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Renal Colic</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group: Patients With Acute Renal Colic In This Group Received Magnesium Sulfate At A Dose Of 2 G Of 50% Solution At 100 Cc At 15 Minutesmagnesium sulfate at a dose of 2 g of 50% solution at 100 cc at 15 minutes.</i_keyword>
      <i_keyword>Control group: In Patients With Acute Renal Colic, Morphine Was Administered At A Dose Of 0.1 Mg / Kg To 100 Cc At 15 Minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Reducing Pain. Timepoint: 20, 30, 60, 120, 180 min. Method of measurement: VAS.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Side Effect. Timepoint: 180 min. Method of measurement: Observation.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-07-16</approval_date>
        <contact_name>Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Shahid Chamran Highway (Evin), adjacent to Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Building No. 2, 6th floor, Secretariat of the Ethics Committee, Research Directorate Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
